| Literature DB >> 35832526 |
Zhicheng Qu1, Tianyuan Wang1,2, Jianfeng Tu3, Weihai Yao1, Xiaolu Pei1, Liancheng Jia1, Ying Cao1, Cunzhi Liu3.
Abstract
Background: Acute renal colic caused by urinary calculi has a considerable impact on the quality of life. Pain relief is the primary goal in the management of patients with acute renal colic caused by urinary calculi. At present, there is no systematic evaluation of the efficacy and safety of manual acupuncture in the treatment of acute renal colic caused by urinary calculi in adults. Objective: To evaluate the efficacy and safety of manual acupuncture in the treatment of acute renal colic caused by urinary calculi in adults.Entities:
Year: 2022 PMID: 35832526 PMCID: PMC9273390 DOI: 10.1155/2022/7140038
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.650
Figure 1Literature screening flow diagram.
The basic features of the included study (acupuncture as a monotherapy).
| Author (year) | No. of participants (T/C) | Mean age or age range (T/C) | Treatment | Control | Outcome measures | Adverse events | |
|---|---|---|---|---|---|---|---|
| Zhang (2021) [ | 39/41 | 47.95 ± 11.07 | 49.00 (41) | Acupuncture + sham medicine | Lornoxicam: 8 mg + sham acupuncture | Response rate VAS (10 min) | T: frequent urination (1); C: nausea (2); dizziness (1) |
| Kaouthar (2018) [ | 54/61 | 42 ± 14.8 | 41.8 ± 13.21 | Acupuncture | Morphine: 0.1 mg/kg | Response rate and time of complete pain relief | T: needle blockage (1); itching/rash/bleeding at insertion point (2); C: dizziness (26); nausea and vomiting (13); drowsiness (1); rash (1); hypotension (1) |
| Xiao (2016) [ | 20/20 | 39.00 ± 12.31 | 39.6 ± 10.56 | Acupuncture | Flurbiprofen Axetil: 50 mg | VAS (10, 30, 120 min) and time duration before pain remission | NR |
| Mehmet (2015) [ | 41/40 | 42.39 (18–71) | 46.3 (19–81) | Acupuncture | Acetaminophen: 1 g | VAS (10, 30, 60, 120 min) | T: none; C: allergic reaction (1); dizziness with vomiting (1) |
| Mehmet (2015) [ | 41/40 | 42.39 (18–71) | 37.98 (18–72) | Acupuncture | Diclofenac: 75 mg | VAS (10, 30, 60, 120 min) | T: none; C: rash (1); abdominal burning/pain (2) |
| Ju (2012) [ | 80/80 | 39 ± 11 | 39 ± 11 | Acupuncture | Scopolamine: 20 mg | Response rate and time duration before pain remission | T: none; C: nausea (17); dizziness (33); fatigue (29); postural hypotension (12) |
| Yang (2011) [ | 27/27 | — | — | Acupuncture | Fortanodyn: 100 mg | Response rate VAS (10, 30, 60, 120 min) and time duration before pain remission | T: none; C: not specified (6) |
| Xiang (2008) [ | 60/60 | — | — | Acupuncture | Anisodamine: 10 mg + Tramadol: 100 mg | Response rate and time duration before pain remission | NR |
| Qiu (2006) [ | 30/30 | 26.7(23–56) | 28.3(21–63) | Acupuncture | Tramadol: 100 mg + Atropine: 0.5 mg | Response rate | NR |
| Xu (2003) [ | 25/27 | 28.32 ± 6.56 | 27.26 ± 6.16 | Acupuncture | Fortanodyn: 100 mg | Response rate, time duration before pain remission, and time of complete pain relief | NR |
| Li (1993) [ | 25/27 | 19–55 | 19–58 | Acupuncture | Atropine: 0.5 mg | Response rate | NR |
| Phenergan: 25 mg | |||||||
| (Fortanodyn: 100 mg) | |||||||
The basic features of the included study (acupuncture as an adjuvant therapy).
| Author (year) | No. of participants (T/C) | Mean age or age range (T/C) | Treatment | Control | Outcome measures | Adverse events | |
|---|---|---|---|---|---|---|---|
| Sun (2021) [ | 30/30 | 38.93 ± 7.95 | 38.52 ± 8.23 | Acupuncture + Phloroglucinol: 120 mg | Pethidine: 50 mg + Phloroglucinol: 120 mg | Response rate VAS (10, 30 min) | NR |
| Xiao (2020) [ | 38/38 | 37.42 ± 4.18 | 37.52 ± 4.31 | Acupuncture + Anisodamine: 5–10 mg | Anisodamine: 5–10 mg | Response rate VAS (60 min) | NR |
| lu (2018) [ | 30/30 | — | — | Acupuncture + Anisodamine: 10 mg | Tramadol: 100 mg + Anisodamine: 10 mg | Response rate | NR |
| Huang (2016) [ | 40/40 | 36.2 | 38.1 | Acupuncture + Pethidine: 50 mg | Pethidine: 50 mg | Response rate | NR |
| Liu (2021) [ | 40/40 | 46.7 (13.11) | 44.8 (14.6) | Acupuncture + Diclofenac: 50 mg | Sham acupuncture + Diclofenac: 50 mg | Response rate VAS (10, 30, 60 min) | T: none; C: none |
Details of needling (STRICTA).
| Author (year) | Number of needles | Names or location of points | Depth of insertion | Responses sought | Needle stimulation | Needle retention time | Needle type |
|---|---|---|---|---|---|---|---|
| Zhang (2021) [ | 4 | SP6, SP9 | 1cun, vertically inserted | Deqi | Manual | 20 min | Aseptic acupuncture needle, specification 0.16 mm × 100 mm, Taixing Tianhe Medical Instrument Co., LTD. Producing Certificate of Jiangsu Province Food & Drug Administration: No. 2013–0073. |
| Sun (2021) [ | — | GB25, BL23, BL40 | GB25 (0.5–1.0 cun), BL23 (1–1.2 cun), BL40 (1.0–1.5 cun), vertically inserted | Deqi | Manual, stimulate per 10 min | 30 min | Disposable acupuncture needles (Hwato) |
| Xiao (2020) [ | — | GB25, BL23, SP6, PC6, pain sensitive | — | Deqi | Manual, may stimulate per 5 min | 15–30 min | — |
| Kaouthar (2018) [ | Left to the discretion of the physician, perhaps 2–16 | BL21, BL22, BL23, BL24, BL26, BL45, BL46, BL47, BL48, BL49 | 1-2 cm, vertically inserted | Deqi | Manual | 20 min | Sterile acupuncture needles were used (0.25 × 50 mm) |
| lu (2018) [ | — | BL23, SP6, ST36 | BL23(1.2–1.5cun), vertically inserted | Deqi | Manual, stimulate per 5 min | 15–20 min | — |
| Xiao (2016) [ | — | Qiu's point | — | Deqi | Manual, dragon—tiger fighting needling method will be performed on needles per 5 min | 15 min | Sterile disposable acupuncture needles (0.3 × 40 mm; Hwato, Suzhou, China) |
| Huang (2016) [ | — | GB25, BL23, SP6, PC6, pain sensitive point | — | Deqi | Manual, stimulate per 5 min | 15–30 min | — |
| Mehmet (2015) [ | — | BL21, BL22, BL23, BL24, BL45, BL46, BL47, BL48 | — | Deqi | Manual | — | Sterile acupuncture needles (0.25 × 25 mm) |
| Ju (2012) [ | — | ST36, PC6 | — | Deqi | Manual, stimulate per 5 min | 30 min | Stainless steel acupuncture needles (0.35 × 40 mm; 0.35 × 25 mm, hwato) |
| Yang (2011) [ | — | KI3, BL60, KI2, BL63 | KI3, BL60, 0.5cun | ||||
| 1cun, vertically inserted | — | Manual | — | — | |||
| Xiang (2008) [ | — | BL23, BL40, ST36, Ashi point | — | — | Manual | — | — |
| Qiu (2006) [ | — | ST36 | — | Deqi | Manual | 30 min | — |
| Xu (2003) [ | — | BL23, BL40, ST36 | — | Deqi | Manual | 25–40 min | — |
| Li (1993) [ | — | BL23, BL40, ST36 | — | Deqi | Manual | 25–40 min | — |
| Liu (2021) [ | 4 | EX-UE7 | Vertically inserted, 0.5 cun | Deqi | Manual | 30 min | Sterile disposable stainless steel acupuncture needles (0.35 × 40 mm; Hwato, Suzhou, China) |
Figure 2Risk of bias graph.
Figure 3Risk of bias summary.
Figure 4Summary of findings.
Figure 5Forest plots of response rate.
Figure 6Forest plots of time duration before pain remission.
Figure 7Forest plots of time of complete pain relief.
Figure 8Forest plots of VAS score at 10 min.
Figure 9Forest plots of VAS score at 30 min.
Figure 10Forest plots of VAS score at 60 min.
Figure 11Forest plots of VAS score at 120 min.
Figure 12Funnel plot of response rate.